JOSE MARIA
ECHAVE SUSTAETA
PROFESOR
Argitalpenak (56) JOSE MARIA ECHAVE SUSTAETA argitalpenak
2023
-
Chronic Airways Assessment Test: psychometric properties in patients with asthma and/or COPD
Respiratory Research, Vol. 24, Núm. 1
-
Cluster Analyses From the Real-World NOVELTY Study: Six Clusters Across the Asthma-COPD Spectrum
Journal of Allergy and Clinical Immunology: In Practice, Vol. 11, Núm. 9, pp. 2803-2811
-
Inhaler Adherence in COPD: A Crucial Step Towards the Correct Treatment
International journal of chronic obstructive pulmonary disease, Vol. 18, pp. 2887-2893
-
Severe Asthma Standard-of-Care Background Medication Reduction With Benralizumab: ANDHI in Practice Substudy
Journal of Allergy and Clinical Immunology: In Practice, Vol. 11, Núm. 6, pp. 1759-1770.e7
2022
-
ANTES Program: One Year on
Archivos de Bronconeumologia
-
Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial
The Lancet Infectious Diseases, Vol. 22, Núm. 12, pp. 1703-1715
-
The burden of mild asthma: Clinical burden and healthcare resource utilisation in the NOVELTY study
Respiratory Medicine, Vol. 200
-
Treatable traits in the NOVELTY study
Respirology, Vol. 27, Núm. 11, pp. 929-940
-
[Translated article] ANTES Program: One Year on
Archivos de Bronconeumologia
2021
-
Characterization of COPD admissions during the first COVID-19 outbreak
International Journal of COPD, Vol. 16, pp. 1549-1554
-
Microspirometers in the Follow-Up of COPD: Advantages and Disadvantages
Archivos de Bronconeumologia
2020
-
Efficacy of FF/UMEC/VI compared with FF/VI and UMEC/VI in patients with COPD: subgroup analysis of the Spain cohort in IMPACT
Therapeutic Advances in Respiratory Disease, Vol. 14
2019
-
Biomarkers of extracellular matrix turnover in patients with idiopathic pulmonary fibrosis given nintedanib (INMARK study): a randomised, placebo-controlled study
The Lancet Respiratory Medicine, Vol. 7, Núm. 9, pp. 771-779
2016
-
Author’s reply
International Journal of COPD
-
The lung function profile of once-daily tiotropium and olodaterol via respimat® is superior to that of twice-daily salmeterol and fluticasone propionate via a accuhaler® (Energito® study)
International Journal of COPD, Vol. 11, pp. 193-205
2014
-
Comorbidity in chronic obstructive pulmonary disease. Related to disease severity?
International journal of chronic obstructive pulmonary disease, Vol. 9, pp. 1307-1314
-
Non-Invasive Ventilation
Clinical Intensive Care Medicine
2013
-
Prevalencia de anemia asociada a la enfermedad pulmonar obstructiva crónica: Estudio de las variables asociadas
Archivos de Bronconeumologia, Vol. 49, Núm. 9, pp. 383-387
-
Treatment of idiopathic pulmonary fibrosis with Ambrisentan: A parallel, randomized trial
Annals of Internal Medicine, Vol. 158, Núm. 9, pp. 641-649
2012
-
Experiencia inicial en el diagnóstico de patologías distintas al carcinoma broncogénico por ecobroncoscopia
Revista de Patologia Respiratoria, Vol. 15, Núm. 4, pp. 136-139